Inhibition of the RAGE products increases survival in experimental models of severe sepsis and systemic infection

Introduction The receptor for advanced glycation end products (RAGE), a multi-ligand member of the immunoglobulin superfamily, contributes to acute and chronic disease processes, including sepsis.